BiTEs offer several advantages over traditional cancer treatments:
1. Target Specificity: BiTEs can be designed to target specific antigens present on cancer cells, reducing the likelihood of off-target effects. 2. Immune System Activation: By engaging T cells directly, BiTEs can elicit a robust immune response against cancer cells. 3. Reduced Toxicity: Compared to conventional chemotherapy, BiTEs may have a more favorable toxicity profile. 4. Overcoming Resistance: BiTEs can potentially overcome resistance mechanisms that limit the efficacy of other forms of immunotherapy.
